Loading...
Last deposits
-
Bastien Estublier, Aline Cano, Célia Hoebeke, Samia Pichard, Didier Scavarda, et al.. Cerliponase alfa changes the natural history of children with neuronal ceroid lipofuscinosis type 2: The first French cohort. European Journal of Paediatric Neurology, 2021, 30, pp.17-21. ⟨10.1016/j.ejpn.2020.12.002⟩. ⟨hal-03578032⟩
-
Louise Gaboriau, Jean-Baptiste Davion, Sandrine Combret, Bénédicte Lebrun-Vignes, Fanny Rocher, et al.. Adalimumab and myositis: A case report and review of the French and international Pharmacovigilance Databases. Neuromuscular Disorders, 2020, 30 (11), pp.915-920. ⟨10.1016/j.nmd.2020.09.026⟩. ⟨hal-03623629⟩
-
R. Quatre, C. Fabre, K. Aubry, P. Bordure, A. Bozorg-Grayeli, et al.. The French Cochlear Implant Registry (EPIIC): Cochlear implant candidacy assessment of off-label indications. European Annals of Otorhinolaryngology, Head and Neck Diseases, 2020, 137, pp.S27-S35. ⟨10.1016/j.anorl.2020.07.012⟩. ⟨hal-03610671⟩
-
Françoise Stanke-Labesque, Elodie Gautier-Veyret, Stephanie Chhun, Romain Guilhaumou. Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment. Pharmacology and Therapeutics, 2020, 215, pp.107627. ⟨10.1016/j.pharmthera.2020.107627⟩. ⟨hal-03598618⟩
-
Marion Lepelley, Charles Khouri, Clémence Lacroix, Laurence Bouillet. Angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibitor–induced angioedema: A disproportionality analysis of the WHO pharmacovigilance database. Journal of Allergy and Clinical Immunology: In Practice, 2020, 8 (7), pp.2406-2408.e1. ⟨10.1016/j.jaip.2020.03.015⟩. ⟨hal-03620949⟩